Vorinostat and Isotretinoin in Treating Patients With High-Risk Refractory or Recurrent Neuroblastoma

Clinical Trial ID NCT01208454

PubWeight™ 2.57^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01208454

Top papers